Pfizer Awarded Partial Summary Judgment in S.C. Federal Lipitor Diabetes MDL



DOCUMENTS
  • Order


CHARLESTON, S.C. — The South Carolina federal judge overseeing the Lipitor multidistrict litigation has granted in part Pfizer’s omnibus motion for summary judgment, ruling that plaintiffs failed to present sufficient evidence that their ingestion of less than 80 mg. of the drug caused them to develop diabetes.

On Jan. 3, Judge Richard M. Gergel of the U.S. District Court for the District of South Carolina held that expert testimony, which is lacking in those cases, is required to prove general and specific causation for plaintiffs to overcome summary judgment.

In February 2014, the Judicial Panel on Multidistrict Litigation created a …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference

December 04, 2024 - New York, NY
Virgin Hotels NYC

MORE DETAILS



HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS